Impact of Breast Milk on the Infectivity and Transmission of Different Viruses "BREASTMILKVIR" (NCT06738563) | Clinical Trial Compass
RecruitingNot Applicable
Impact of Breast Milk on the Infectivity and Transmission of Different Viruses "BREASTMILKVIR"
France75 participantsStarted 2025-09-10
Plain-language summary
Exclusive breastfeeding during the first six months of life and continued breastfeeding for at least 24 months constitute the optimal feeding method for infants and young children.
However, breast milk and breastfeeding can be significant pathways for the transmission of certain viruses.
The objective of this study is to examine the influence of human breast milk and its composition on viral infectivity and viral transmission of the HTLV-1 virus and arboviruses such as Zika virus, yellow fever, dengue, and tick-borne encephalitis.
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age \> 18 years
* Female gender
* Lactarium Ile-de-France donors
* Subjects covered by a Social Security scheme, excluding State Medical Aid
No inclusion criteria:
\- Women opposing participation in the study
Exclusion Criteria:
\- Positive HIV, HBV, HCV and HTLV serologies (Lactarium exclusion criteria)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study focuses on collecting breast milk to study how it interacts with viruses like Zika, dengue, yellow fever, HTLV-1, and tick-borne encephalitis — can you help me understand whether my personal history with any of these viruses, or my risk of exposure to them, makes my participation especially relevant or raises any concerns?
2Since this trial is studying viral transmission through breast milk, what does that mean for my own breastfeeding practice during or after participation — could being in this study affect any guidance you'd give me about breastfeeding my baby?
3The study is looking at how breast milk composition influences how viruses spread — will my milk samples be used in laboratory experiments involving live viruses, and are there any privacy or data considerations I should know about before agreeing?
4Because this trial is listed as phase 'not applicable,' meaning it's a sample collection and laboratory study rather than a treatment trial, what would you say are the main risks or burdens of participation for me as a breastfeeding person, and is there anything about my health situation that might make donating breast milk complicated?
5Are there alternative ways I could contribute to research on breastfeeding and infectious disease if this particular study isn't the right fit for me right now?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Study the influence of breast milk and its composition on viral infectivity and oral transmission of HTLV-1 and arboviruses such as Zika virus, yellow fever virus, dengue virus, and tick-borne encephalitis virus.